Jens Juul Holst

Jens Juul Holst

Professor

ORCID: 0000-0001-6853-3805

Publication year:
All
21 - 30 out of 59Page size: 10
  1. 2004
  2. Published

    Enhancing insulin secretion: novel approaches to glucose control. / Holst, Jens Juul.

    In: Diabetes Voice, No. 49, 2004, p. 20-22.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. / Holst, Jens Juul; Deacon, Carolyn F.

    In: Current Opinion in Pharmacology, Vol. 4, No. 6, 2004, p. 589-96.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    On the physiology of GIP and GLP-1. / Holst, Jens Juul.

    In: Horm Metab Res, No. 36, 2004, p. 747-754.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. / Holst, Jens Juul; Gromada, Jesper.

    In: American Journal of Physiology: Endocrinology and Metabolism, Vol. 287, No. 2, 2004, p. E199-206.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism. / Holst, Jens Juul; Ørskov, Cathrine.

    In: Diabetes, Vol. 53 Suppl 3, 2004, p. S197-204.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors. / Holst, Jens Juul.

    In: Expert Opinion on Emerging Drugs, Vol. 9, No. 1, 2004, p. 155-66.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide-streptozotocin Göttingen minipig after oral glucose in vivo and in the perfused pancreas. / Larsen, M.O.; Rolin, B.; Gotfredsen, C.F.; Carr, R.D.; Holst, Jens Juul.

    In: Diabetologia, No. 47, 2004, p. 1873-1878.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Intravenous glucagon-like peptide 1 (GLP-1) normalizes blood glucose after major surgery in patients with type 2 diabetes. / Meier, J.J.; Weyhe, D.; Michaely, M.; Senkal, M.; Zumtobel, V.; Nauck, M.A.; Holst, J.J.; Schmidt, W.E.; Gallwitz, B.

    In: Critical Care Medicine, No. 32, 2004, p. 848-851.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. / Meier, Juris J; Goetze, Oliver; Anstipp, Jens; Hagemann, Dirk; Holst, Jens Juul; Schmidt, Wolfgang E; Gallwitz, Baptist; Nauck, Michael A.

    In: American Journal of Physiology: Endocrinology and Metabolism, Vol. 286, No. 4, 04.2004, p. E621-5.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes. / Meier, Juris J; Weyhe, Dirk; Michaely, Mark; Senkal, Metin; Zumtobel, Volker; Nauck, Michael A; Holst, Jens Juul; Schmidt, Wolfgang E; Gallwitz, Baptist.

    In: New Horizons (Baltimore), Vol. 32, No. 3, 03.2004, p. 848-51.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 Next

ID: 4207